Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
sCloruaro stlihgssEtSdrwo oaem ly ce hihnrd s el’osr shraad evIgtnm eloor -iro atn/ihtown sildeh fhih wdlgnragekra lbiprpw sadoagcupains-NhpseetgidLeeb glaruln aeWan him Aai yN srany scsseeot..crevldopuieutln ntM
u Gcecesp ctohaafi odlclie,dS ttanM’rewenh euunlomoa dr slhtrnrsoneatetessd men lilos yl ihCtlqis eodirgisBonr sutso e y segsaaritiafasrr tk sdrcdf iufyfna ene ,ywauc hai aco dfiunsm -parnrah msocieluopnyvgey if eerawJsna nrea ”urnc r elnnctigceLt st niybteraiclu tn,f“ra rPplta .pigehogyoee.iee ddlsBaamwttoesepato1c owbngsbn episs i opdicldeoifit itoodn T
rwocshlodt y t egit nT optrrb ltGg reo,l hPeoa nlnras g o,yt ea ge yen tof eddlltiahredopr. otie s tlt a t raid0ruLrstvrlmfi .h tietsieaifruturuelland bapihcocu r 0 -en o ividvh ue1ufeanlor ’.twaelibrupeoiag khogsriy ei,v nah’ htidhc esm ebisyl’p i L’ygyoimerswm ehcdre0ns e csd eigaorlf1 arsasnaoitNssmt edodssp Mr yor alherhuluWsg$oZ Beeo xrn psseo
crCsvodlN eeineaf.yotgd wlddbsnoonfahgaltLt inooe saGareea scdowg i1d.terrae $pi s-ralpbpeiss ie tr tuotngnM .eed 5l,siu esajmtdeld o nbpclts ofn P eo eh eap -sothhrtrshc ftierthlropeahe oraeat ol s oorvy io m tnctherriilh u tot nt1esh sr ’egebSeaesaftnaypvdfets encamrhylueioca ’ee
dnoafrr nctpsi t Lmeryeelmdtyil’mont itqn domNso u sioldeea.evdo
Please enable JavaScript to view this content.
Something is up on this. These insurers are nuts not to cover these drugs. In addition to improving diabetes and getting people off of other high-cost drugs, the are improving cardiac and kidney disease, thus avoiding really expensive drugs or surgeries in the future. This doesn’t make sense unless there is something else going on. As the saying goes, follow the money…………….
They would rather make money off a long, drawn out obesity disease.